127 related articles for article (PubMed ID: 20808263)
1. In situ protection against islet allograft rejection by CTLA4Ig transduction.
Londrigan SL; Sutherland RM; Brady JL; Carrington EM; Cowan PJ; d'Apice AJ; O'Connell PJ; Zhan Y; Lew AM
Transplantation; 2010 Nov; 90(9):951-7. PubMed ID: 20808263
[TBL] [Abstract][Full Text] [Related]
2. Prolonged local expression of anti-CD4 antibody by adenovirally transduced allografts can promote long-term graft survival.
Londrigan SL; Sutherland RM; Brady JL; Zhan Y; Li R; Estella E; Kay TW; Lew AM
J Gene Med; 2006 Jan; 8(1):42-52. PubMed ID: 16075436
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo and systemic transfer of adenovirus-mediated CTLA4Ig gene combined with a short course of FK506 therapy prolongs islet graft survival.
Akamaru Y; Ito T; Uchikoshi F; Maeda A; Tori M; Kiyomoto T; Komoda H; Miao G; Matsuda H
Transpl Immunol; 2003; 11(1):91-100. PubMed ID: 12727480
[TBL] [Abstract][Full Text] [Related]
4. Blockade of OX40 signals enhance survival of xenoislet grafts in spontaneously diabetic NOD mice.
Honkanen-Scott M; Johnson J; Hering B; Bansal-Pakala P
Transplant Proc; 2008 Mar; 40(2):483-5. PubMed ID: 18374109
[TBL] [Abstract][Full Text] [Related]
5. Prolongation of islet allograft survival by coexpression of CTLA4Ig and CD40LIg in mice.
Li ZL; Xue WJ; Tian PX; Ding XM; Tian XH; Feng XS; Hou J
Transplant Proc; 2007 Dec; 39(10):3436-7. PubMed ID: 18089400
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of rejection in murine islet xenografts by CTLA4Ig and CD40LIg gene transfer.
Zhang J; Li H; Jiang N; Wang GY; Fu BS; Wang GS; Yang Y; Chen GH
Chin Med J (Engl); 2010 Nov; 123(21):3106-9. PubMed ID: 21162964
[TBL] [Abstract][Full Text] [Related]
7. CTLA4Ig adenoviral gene transfer induces long-term islet rat allograft survival, without tolerance, after systemic but not local intragraft expression.
Laumonier T; Potiron N; Boeffard F; Chagneau C; Brouard S; Guillot C; Soulillou JP; Anegon I; Le Mauff B
Hum Gene Ther; 2003 Apr; 14(6):561-75. PubMed ID: 12718766
[TBL] [Abstract][Full Text] [Related]
8. Effects of gene transfer CTLA4Ig and anti-CD40L monoclonal antibody on islet xenograft rejection in mice.
Zhang J; Li H; Jiang N; Zhang Q; Wang GS; Yi HM; Fu BS; Wang GY; Yang Y; Chen GH
Transplant Proc; 2010 Jun; 42(5):1835-7. PubMed ID: 20620534
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells.
Chahine AA; Yu M; McKernan MM; Stoeckert C; Lau HT
Transplantation; 1995 May; 59(9):1313-8. PubMed ID: 7762068
[TBL] [Abstract][Full Text] [Related]
10. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
Cheng J; Sun J; Sung RS
Transpl Immunol; 2009 May; 21(1):33-42. PubMed ID: 19224710
[TBL] [Abstract][Full Text] [Related]
11. Combined costimulation blockade prevents rejection of allogeneic islets in mice.
Malm H; Påhlman C; Veress B; Corbascio M; Ekberg H
Scand J Immunol; 2006 Oct; 64(4):398-403. PubMed ID: 16970681
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated CTLA4Ig or CD40Ig gene transfer delays pancreatic islet rejection in a rat-to-mouse xenotransplantation model after systemic but not local expression.
Potiron N; Chagneau C; Boeffard F; Soulillou JP; Anegon I; Le Mauff B
Cell Transplant; 2005; 14(5):263-75. PubMed ID: 16052908
[TBL] [Abstract][Full Text] [Related]
13. [Effects of gene transfer CTLA4-Ig and anti-CD154 monoclonal antibody on the rejection of rat islet xenografts].
Zhang J; Chen GH; Weng JP; Lu MQ; Yang Y; Cai CJ; Xu C; Li H
Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):136-9. PubMed ID: 18509975
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
[TBL] [Abstract][Full Text] [Related]
15. Enhancing engraftment of neonatal porcine xenoislet with CTLA4Ig and nordihydroguaiaretic acid.
Fu SH; Chen YT; Chiang CH; Hsu BR
Transplant Proc; 2006 Dec; 38(10):3283-5. PubMed ID: 17175250
[TBL] [Abstract][Full Text] [Related]
16. Permanent acceptance of mitomycin C-treated islet allograft.
Matsuyama S; Gunji T; Ise K; Sato Y; Saito T; Gotoh M
Transplantation; 2003 Jul; 76(1):65-71. PubMed ID: 12865788
[TBL] [Abstract][Full Text] [Related]
17. Secretion of CTLA4Ig by an SV40 T antigen-transformed islet cell line inhibits graft rejection against the neoantigen.
Lew AM; Brady JL; Silva A; Coligan JE; Georgiou HM
Transplantation; 1996 Jul; 62(1):83-9. PubMed ID: 8693551
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic beta-islet cells correct diabetes and resist immune rejection.
Pericin M; Althage A; Freigang S; Hengartner H; Rolland E; Dupraz P; Thorens B; Aebischer P; Zinkernagel RM
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8203-6. PubMed ID: 12060765
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of CTLA4Ig secreted by transgenic fetal pancreas allografts.
Sutherland RM; Brady JL; Georgiou HM; Thomas HE; Lew AM
Transplantation; 2000 May; 69(9):1806-12. PubMed ID: 10830215
[TBL] [Abstract][Full Text] [Related]
20. Islet allograft rejection is independent of toll-like receptor signaling in mice.
Hutton MJ; Westwell-Roper C; Soukhatcheva G; Plesner A; Dutz JP; Verchere CB
Transplantation; 2009 Nov; 88(9):1075-80. PubMed ID: 19898202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
